The role of cytokines and their inhibitors in arthritis (Q35233166)

7 August 2017

1 reference

title

The role of cytokines and their inhibitors in arthritis (English)

1 reference

7 August 2017

J. M. Dayer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1326412

13 September 2022

H. Fenner

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1326412

13 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1326412

13 September 2022

publication date

1 June 1992

1 reference

Bailliere's clinical rheumatology

7 August 2017

published in

1 reference

7 August 2017

volume

6

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

485-516

1 reference

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Interleukin 1 receptor antagonist. A new member of the interleukin 1 family

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Modulation of endotoxic activity of lipopolysaccharide by high-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Interactions between tumor necrosis factor-alpha, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Joint destruction in arthritis: metalloproteinases in the spotlight

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

A natural interleukin 1 (IL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic islets

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Tumour necrosis factor in synovial exudates

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Human cytokine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Plasma levels of interleukin-1-alpha in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis results of two metaanalyses

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Characterization of a specific 20- to 25-kD interleukin-1 inhibitor from cultured human lung macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Interleukin 1 receptor antagonist in human epidermis and cultured keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Rheumatoid arthritis. Pathophysiology and implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Mechanisms controlling the level of receptors for tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Human recombinant interleukin-1 beta and -alpha, but not recombinant tumor necrosis factor alpha stimulate ACTH release from rat anterior pituitary cells in vitro in a prostaglandin E2 and cAMP independent manner

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Cytokines of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Immunogenetic and cellular immune mechanisms in rheumatoid arthritis: relevance to new therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Immunotherapy of rheumatic diseases--practice and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Mononuclear cell-conditioned medium containing mononuclear cell factor (MCF), homologous with interleukin 1, stimulates collagen and fibronectin synthesis by adherent rheumatoid synovial cells: effects of prostaglandin E2 and indomethacin.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Mechanisms of matrix degradation in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Tumor necrosis factor in the serum of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

How does interleukin 1 activate cells? Cyclic AMP and interleukin 1 signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. Different strategies of IL-1 production and processing in monocytes and keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

1 reference

7 January 2021

Natural and recombinant interleukin 1 receptor antagonist does not inhibit human T-cell proliferation induced by mitogens, soluble antigens or allogeneic determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Enzymatic degradation of tumor necrosis factor by activated human neutrophils: role of elastase

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Elevated substance p and accelerated cartilage degradation in rabbit knees injected with interleukin-1 and tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Antiproliferative effects of methotrexate on peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Isolation and characterization of a tumor necrosis factor binding protein from urine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

How does interleukin 1 activate cells? Interleukin 1 signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Shedding of tumor necrosis factor receptors by activated human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Gold-specific T cells in rheumatoid arthritis patients treated with gold

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Production of interleukin-1 (IL-1) and a specific IL-1 inhibitor during human monocyte-macrophage differentiation: influence of GM-CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Anti-interleukin-1α autoantibodies in humans: Characterization, isotype distribution, and receptor-binding inhibition—Higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Molecular cloning and expression of a receptor for human tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

A human inhibitor of tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Characterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

The effects of methotrexate on the production and activity of interleukin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Occurrence of interleukin-1 in human synovial fluid: detection by RIA, bioassay and presence of bioassay-inhibiting factors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Inhibition of leukotriene B4 synthesis in neutrophils from patients with rheumatoid arthritis by a single oral dose of methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Purification and characterization of a novel soluble receptor for interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

The two different receptors for tumor necrosis factor mediate distinct cellular responses

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-β

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Inflammatory and immunomodulatory roles of TGF-beta.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Synovial fluid concentration of five different cytokines in rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Some recombinant human cytokines stimulate glycosaminoglycan synthesis in human synovial fibroblast cultures and inhibit it in human articular cartilage cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Characteristics of tumor necrosis factor production in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

Role of the endothelium in chronic inflammatory synovitis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980186-4

7 January 2021

10.1016/S0950-3579(05)80186-4

Identifiers

DOI

1 reference

7 August 2017

1 reference